PROTAC erf3a Degrader-1

PROTAC erf3a Degrader-1 (Compound C63) is an orally active PROTAC erf3a Degrader. PROTAC erf3a Degrader-1 inhibits cancer cell proliferation (eg: 22Rv1) . PROTAC erf3a Degrader-1 can be used for research of prostate cancer, ovarian cancer, liver cancer, cervical cancer, leukemia, breast cancer. (Red: erf3a ligand (HY-13778) ; Black: linker (HY-163960) ; Blue: CRBN ligand (HY-41547) ) [1].

Product Specifications

CAS Number

[3033871-19-8]

UNSPSC

12352005

Target

PROTACs

Type

Reference compound

Related Pathways

PROTAC

Applications

Cancer-programmed cell death

Field of Research

Cancer

Assay Protocol

https://www.medchemexpress.com/protac-erf3a-degrader-1.html

Purity

99.44

Solubility

DMSO : 60 mg/mL (ultrasonic)

Smiles

O=C(N1[C@@H]2C(NC(CC2)=O)=O)C3=CC=CC(N[C@H](CCC4)C[C@@H]4NC5=CC(NC([C@H]6CC[C@]([C@@]7([H])[C@@](CC8)([H])[C@@]9([C@@](NC(C=C9)=O)([H])CC7)C)([H])[C@]86C)=O)=CC=C5)=C3C1=O

Molecular Formula

C44H52N6O6

Molecular Weight

760.92

References & Citations

[1]Guangliang Yu, et al. Medicine for treating human tumor by eRF3a targeting protein degradation mechanism. Patent. CN117801051A.

Shipping Conditions

Blue Ice

Storage Conditions

-20°C (Powder, protect from light, stored under nitrogen)

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

45963036 100 µg

SYNCRIP Protein Lysate (Rat) with C-HA Tag

Ask

View Details

C2380-09EX-HRP 100 µL

CD28 (MGC138290, T cell Antigen CD28, T cell Specific Surface Glycoprotein CD28, Tp44) (HRP) discontinued

Ask

View Details

51651091 4x 500 ng

ZNF595-set siRNA/shRNA/RNAi Lentivector (Human)

Ask

View Details

034554-Biotin 200 µL

DDX3Y, NT (DDX3Y, DBY, ATP-dependent RNA helicase DDX3Y, DEAD box protein 3, Y-chromosomal) (Biotin) discontinued

Ask

View Details